Experimental Agent Shows Promise in Slowing Genetic Form of ALS Experimental Agent Shows Promise in Slowing Genetic Form of ALS

Researchers successfully target elevated levels of a harmful protein, offering hope to people with a genetic form of amyotrophic lateral sclerosis.Medscape Medical News
Source: Medscape Neurology and Neurosurgery Headlines - Category: Neurology Tags: Neurology & Neurosurgery News Source Type: news